Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
7.23
-0.33 (-4.37%)
Jun 5, 2025, 4:00 PM - Market closed
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $423.19 million as of June 6, 2025. Its market cap has decreased by -75.02% in one year.
Market Cap
423.19M
Enterprise Value
340.82M
1-Year Change
-75.02%
Ranking
Category
Stock Price
$7.23
Market Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $423.19M, a decrease of -80.61%. That is a compound annual growth rate of -32.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2025 | 423.19M | -18.82% |
| Dec 31, 2024 | 521.27M | -84.36% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 673.53B |
| Johnson & Johnson | 371.62B |
| AbbVie | 330.12B |
| Novo Nordisk | 323.14B |
| UnitedHealth Group | 272.71B |
| Abbott Laboratories | 230.75B |
| Novartis AG | 228.01B |
| AstraZeneca | 222.18B |